Previously treated cases tested for RR-/MDR-TB in Afghanistan
Afghanistan: Previously treated cases tested for RR-/MDR-TB was 100.0% in 2024. ◆ Volatile
Latest (2024)
100.0%
Change on year
unchanged
World rank
1st
of 180 countries
All-time high
100.0%
in 2019
All-time low
1.7%
in 2013
Years of data
13
2010–2024
Previously treated cases tested for RR-/MDR-TB in Afghanistan, 2010–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Afghanistan recorded 100.0% for previously treated cases tested for rr-/mdr-tb in 2024. That is the highest value across all 13 years on record.
Compared with earlier readings it is up 1,076.5% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Afghanistan peaked at 100.0% in 2019 and was at its lowest, 1.7%, in 2013.
That places Afghanistan 1st out of 180 countries with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Afghanistan, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 2.6% | — |
| 2012 | 2.0% | -23.1% |
| 2013 | 1.7% | -15.0% |
| 2014 | 8.5% | +400.0% |
| 2015 | 3.5% | -58.8% |
| 2016 | 58.0% | +1557.1% |
| 2017 | 95.0% | +63.8% |
| 2018 | 95.0% | +0.0% |
| 2019 | 100.0% | +5.3% |
| 2020 | 100.0% | +0.0% |
| 2021 | 56.0% | -44.0% |
| 2023 | 100.0% | +78.6% |
| 2024 | 100.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 40.7% | 1.7% | 100.0% | 9 |
| 2020s | 89.0% | 56.0% | 100.0% | 4 |
Countries ranked near Afghanistan
- 1 Cote d'Ivoire 100.0% compare
- 1 Zambia 100.0% compare
- 1 Lithuania 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Sri Lanka 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Fiji 100.0% compare
- 1 Norway 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Luxembourg 100.0% compare
- 1 Armenia 100.0% compare
- 1 Gambia 100.0% compare
- 1 Ghana 100.0% compare
- 1 Yemen 100.0% compare
- 1 Oman 100.0% compare
- 1 Brunei 100.0% compare
- 1 Togo 100.0% compare
- 1 Israel 100.0% compare
- 1 Cameroon 100.0% compare
- 1 Jamaica 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Cyprus 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Vietnam 100.0% compare
- 1 Belize 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Moldova 100.0% compare
- 1 Comoros 100.0% compare
- 1 Kazakhstan 100.0% compare
- 1 Laos 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Benin 100.0% compare
- 1 Jordan 100.0% compare
- 1 Puerto Rico 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Congo 100.0% compare
- 1 Eswatini 100.0% compare
- 1 Micronesia (country) 100.0% compare
- 1 Iceland 100.0% compare
- 1 Belarus 100.0% compare
- 1 Albania 100.0% compare
- 1 Mauritania 100.0% compare
- 1 Bhutan 100.0% compare
- 1 Tuvalu 100.0% compare
- 1 Malta 100.0% compare
- 1 Iraq 100.0% compare
- 1 South Korea 100.0% compare
- 1 Papua New Guinea 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Zimbabwe 100.0% compare
- 1 Andorra 100.0% compare
- 1 Turkmenistan 100.0% compare
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Heat deaths vs projected death rates 812.4 (2090)
- Un projection of annual infant deaths 14,735 (2100)
- Population ages 0-14, female, annual growth rate 2.05 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0005 units per US$ of GDP (2024)
- Population ages 0-14, female, per capita 0.2081 units per person (2025)
- Population ages 0-14, male, annual growth rate 1.99 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0005 units per US$ of GDP (2024)
- Population ages 0-14, male, per capita 0.2175 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Afghanistan?
- Previously treated cases tested for rr-/mdr-tb in Afghanistan was 100.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Afghanistan?
- The highest recorded value was 100.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Afghanistan?
- The lowest recorded value was 1.7% in 2013.
- How does Afghanistan rank for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Afghanistan?
- Over the last ten years it is up 1,076.5%. The long-run trend across the full record is volatile.
- Where does this Afghanistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).